LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

LLY

917.46

+0.11%↑

JNJ

237.66

+0.19%↑

ABBV

206.13

-1.03%↓

NVS

148.1

-1.11%↓

AZN

188.8

+0.2%↑

Search

Quanterix Corp

Fermé

SecteurSoins de santé

4.4 -2.87

Résumé

Variation du prix de l'action

24h

Actuel

Min

4.33

Max

4.52

Chiffres clés

By Trading Economics

Revenu

10M

-23M

Ventes

3.7M

44M

Marge bénéficiaire

-52.712

Employés

450

EBITDA

15M

-17M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+65.93% upside

Dividendes

By Dow Jones

Prochains Résultats

11 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-75M

221M

Ouverture précédente

7.27

Clôture précédente

4.4

Sentiment de l'Actualité

By Acuity

35%

65%

112 / 351 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Neutral Evidence

Quanterix Corp Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 mars 2026, 22:51 UTC

Résultats

AIA Group Value of New Business Rose in 2025, Plans $1.7 Billion New Share Buyback

18 mars 2026, 21:40 UTC

Acquisitions, Fusions, Rachats

Constellation Energy to Sell Portfolio of Assets for $5 Billion to Satisfy Regulators

18 mars 2026, 20:31 UTC

Résultats

Micron 2Q Sales Nearly Triple Amid Tight Memory Supply

18 mars 2026, 23:49 UTC

Market Talk
Principaux Événements d'Actualité

Nikkei May Fall on Renewed Concerns About Higher Energy Prices -- Market Talk

18 mars 2026, 23:31 UTC

Market Talk

Gold Rises on Likely Technical Recovery -- Market Talk

18 mars 2026, 22:49 UTC

Market Talk

New Zealand's Economic Recovery Has Yet to Find Footing -- Market Talk

18 mars 2026, 22:41 UTC

Market Talk

Woodside Energy Opts for 'Safe, Experienced' Choice as CEO -- Market Talk

18 mars 2026, 22:36 UTC

Résultats

AIA Group Value of New Business Rose in 2025, Plans $1.7B New Share Buyback

18 mars 2026, 22:24 UTC

Résultats

AIA Group Announces New Share Buyback of $1.7B >1299.HK

18 mars 2026, 22:23 UTC

Résultats

AIA Group 2025 Value of New Business Margin Was 58.5%, Up 3.6 Ppt on Year >1299.HK

18 mars 2026, 22:23 UTC

Résultats

AIA Group 2025 Value of New Business $5.52B Vs. $4.71B >1299.HK

18 mars 2026, 21:58 UTC

Résultats

Micron Sales Nearly Triple Amid Tight Memory Supply -- Update

18 mars 2026, 21:55 UTC

Market Talk
Résultats

Global Equities Roundup: Market Talk

18 mars 2026, 21:55 UTC

Market Talk
Résultats

Micron's Phone, PC Business Could Shrink Due to Memory Shortage -- Market Talk

18 mars 2026, 21:40 UTC

Market Talk

Fuel Price Rise Equates to 20 Bps Rate Hike on Australian Households -- Market Talk

18 mars 2026, 21:16 UTC

Market Talk

More Procter & Gamble Alumni Join Strobel at Coty -- Market Talk

18 mars 2026, 21:00 UTC

Principaux Événements d'Actualité

Iran War Puts Pressure on Japan's Economy. Takaichi Is In a Bind. -- Barrons.com

18 mars 2026, 20:58 UTC

Résultats

Micron 2Q Gross Margin Nearly Doubled Due to Higher Pricing, CFO Says

18 mars 2026, 20:41 UTC

Résultats

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mars 2026, 20:29 UTC

Résultats

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mars 2026, 20:25 UTC

Résultats

Micron Reports Extraordinary Earnings. Its Growth Is Accelerating. -- Barrons.com

18 mars 2026, 20:17 UTC

Résultats

These Stocks Are Today's Movers: Micron, Swarmer, Lumentum, Trade Desk, Macy's, Williams-Sonoma, and More -- Barrons.com

18 mars 2026, 20:14 UTC

Market Talk

Airlines Can't Offset Higher Fuel Prices for Long -- Market Talk

18 mars 2026, 20:09 UTC

Résultats

Micron Reports Extraordinary Earnings. The Stock Is Up. -- Barrons.com

18 mars 2026, 20:07 UTC

Résultats

Micron Technology Raises Qtr Dividend to 15c Vs. 11.5c >MU

18 mars 2026, 20:06 UTC

Résultats

Micron Technology Board Has Approved 30% Increase in Qtrly Div >MU

18 mars 2026, 20:04 UTC

Résultats

Micron Technology 2Q Operating Cash Flow $11.9 B >MU

18 mars 2026, 20:04 UTC

Résultats

Micron Technology Sees 3Q Operating Expenses About $1.6 B >MU

18 mars 2026, 20:04 UTC

Résultats

Micron Technology Sees 3Q Gross Margin About 81% >MU

18 mars 2026, 20:03 UTC

Résultats

Micron Technology Sees 3Q Adj EPS $19.15 +/- 40c >MU

Comparaison

Variation de prix

Quanterix Corp prévision

Objectif de Prix

By TipRanks

65.93% hausse

Prévisions sur 12 Mois

Moyen 7.5 USD  65.93%

Haut 8 USD

Bas 7 USD

Basé sur 2 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

2 ratings

0

Achat

2

Maintien

0

Vente

Score Technique

By Trading Central

5.34 / 6.015Support & Résistance

Court Terme

Neutral Evidence

Moyen Terme

Bullish Evidence

Long Terme

No Evidence

Sentiment

By Acuity

112 / 351Classement par Soins de santé

Sentiment de l'Actualité

Indications Haussières

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Supérieur à la moyenne

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Quanterix Corp

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.
help-icon Live chat